GLP-1 RA Shortage Search

GLP-1 RA Shortage Search


There are supply disruptions for Ozempic (s/c Semaglutide) and Trulicity (s/c Dulaglutide), expected to last until January 2023. Patients with both Type 1 and Type 2 diabetes are being treating increasingly with these weekly GLP-1 analogue injections, commonly prescribed in primary care.
On 6 September 2022 the Primary Care Diabetes Society released a position statement issued advice about options for primary care prescribers within the context of Type 2 diabetes. They summarise that, following the Department of Health and Social Care's medicine supply notifications on 30 September 2022:
  • Ozempic 1 mg solution for injection is out of stock until week commencing 17 October 2022. Thereafter, supply will only be available for existing patients until January 2023.
  • Ozempic 0.5 mg solution for injection remains available but can only support a partial uplift in demand. Check with local pharmacy teams; in regions where there is stock of the 0.5 mg dose, temporary reduction to this dose may be considered.
  • Supplies of Trulicity 0.75 mg, 1.5 mg, 3 mg and 4.5 mg solution for injection devices are limited until January 2023. Supply will only be available for existing patients.
Key options for switching are summarised on page 2 of their document.

Key features

  • Primary Care IT has prepared SystmOne & EMIS searches to help practices identify and contact patients who are on these preparations.
  • Suggested contact messages are included in the PCDS statement and here:
    • "From your records, we note that you are currently taking Ozempic (semaglutide) Trulicity (dulaglutide) injections for type 2 diabetes.
    • There are disruptions in the supply chain of this medication, which may affect your ability to continue therapy, lasting until January 2023.
    • We would like to offer you alternative therapy to bridge this gap in supply and ask that you contact the surgery to discuss at your earliest convenience."
  • Since the position for patients with Type 1 diabetes may be different than in Type 2, Primary Care IT also advise discussion with their secondary care team before making switches to alternative therapies or formulations as outlined. Searches have been prepared to help identify both groups and those who appear not to have diabetes from the records.
6 search groups are available, for practice prescribing teams can choose how best to use:
  1. All patients on these injections, regardless of reason.
  2. Patients on Trulicity (Dulaglutide), regardless of reason.
  3. Patients on Ozempic (Semaglutide), regardless of reason.
  4. Patients with Type 1 diabetes on one of the preparations.
  5. Patients with Type 2 diabetes on one of the preparations.
  6. Patients with no diabetes on one of the preparations, who may be prescribed by other clinics for weight loss (off license).

    • Related Articles

    • Diabetes Audit search folder

      GLP-1 agonist stock shortage This folder created specifically in response to the July 2023 GLP-1 stock shortage sits within the Diabetes folder of 012 Clinical Searches. It is also available as a standalone folder to support a rapid deployment to ...
    • Chaperone search folder

      The Chaperone search folder is part of 012 Audit ready (v3.1) The Chaperone folder contains a search and report which can be used for monitoring and audit purposes. The search RWA-151) Intimate examination identifies patients who have had a code ...
    • Core20Plus5 search folder

      The Core20Plus5 search folder is part of 012. Clinical searches (v4) Core20PLUS5 is an NHS England & NHS Improvement initiative created to identify key groups of patients in order to tackle Health Inequalities. The three areas are: Core20 - the most ...
    • Chest x-ray search folder

      The Chest x-ray search folder is part of 012. Audit ready This folder contains a search and associated report which can be used for monitoring and audit purposes The search RWA-161 simply looks for any chest x-ray code from the past 3 months up until ...
    • Anti-epileptics & pregnancy search folder

      The Anti-epileptics & pregnancy search folder is part of 012. Audit Ready This folder contains two searches with their associated reports which can be used for monitoring and audit purposes. The searches RWA-001 and RWA-002 are very similar in their ...